An updated patent review of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors (2020-present).
- DOI
- 10.1080/13543776.2026.2694586
- Published
- 2026 Aug
- Container
- Expert opinion on therapeutic patents
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/13543776.2026.2694586,
title = {An updated patent review of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors (2020-present).},
author = {Abdallah M and Keddis PM and Keddis TM and El-Gamil DS and Abadi AH and Kii I and Engel M and Abdel-Halim M},
year = {2026},
journal = {Expert opinion on therapeutic patents},
doi = {10.1080/13543776.2026.2694586},
url = {https://doi.org/10.1080/13543776.2026.2694586}
}RIS
TY - JOUR TI - An updated patent review of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors (2020-present). AU - Abdallah M AU - Keddis PM AU - Keddis TM AU - El-Gamil DS AU - Abadi AH AU - Kii I AU - Engel M AU - Abdel-Halim M PY - 2026 JO - Expert opinion on therapeutic patents DO - 10.1080/13543776.2026.2694586 UR - https://doi.org/10.1080/13543776.2026.2694586 ER -
APA
M, A., PM, K., TM, K., DS, E., AH, A., I, K., M, E., & M, A. (2026). An updated patent review of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors (2020-present).. Expert opinion on therapeutic patents. https://doi.org/10.1080/13543776.2026.2694586
Source records
- pubmed · retrieved 2026-09-26T08:53:19.126Z